Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Cancer Res. 2019 Jul 4;79(17):4491–4502. doi: 10.1158/0008-5472.CAN-18-3645

Figure 2:

Figure 2:

PARG inhibition is synthetic lethal with HR deficiency in PDAC cells. (A) Pico Green assays were performed after 5 days of treatment with PDDX-001, PDDX-002 and PDDX-004 to analyze relative cell survival in PDAC cells (MIA Paca-2, PANC-1). (B, C and D) Relative cell survival of MIA PaCa-2 and Hs 766T treated with PDDX-001 over 3, 5 and 7 days; KPC BRCA WT and KPC BRCA2 null cells as well as pancreatic cancer patient derived xenograft cell lines (SPC_126, SPC_122, SPC_144). (E) Synthetic lethality with PDDX-01 and siRNA DDR genes in MIA PaCa-2 and PANC-1 cells. Representative graphs from n=2 for (A) and n=3 for (B, C, D and E) are shown.